Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
<p align="LEFT">Buserelin is one of the first synthetic gonadotropin-releasing hormone agonists. The R.M. Fronshtein Clinic of Urology, I.M. Sechenov First Moscow State Medical University, has experience in using Buserelin depot in 32 patients with metastatic prostate cancer. The res...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-12-01
|
| Series: | Андрология и генитальная хирургия |
| Subjects: | |
| Online Access: | http://agx.abvpress.ru/index.php/jour/article/view/110 |
Search Result 1
Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
Published 2014-12-01
Get full text
Article